Cargando…

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction

In heart failure with preserved ejection fraction (HFpEF), natriuretic peptide (NP) levels are frequently lower. In several trials, the outcome differed between patients with low and high NP levels. This suggests that NP could be used to identify distinct stages of left ventricular (LV) remodeling a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dal Canto, Elisa, Scheffer, Marielle, Kortekaas, Kirsten, Driessen-Waaijer, Annet, Paulus, Walter J., van Heerebeek, Loek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045594/ https://www.ncbi.nlm.nih.gov/pubmed/36979846 http://dx.doi.org/10.3390/biomedicines11030867

Ejemplares similares

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
por: Scheffer, Mariëlle, et al.
Publicado: (2020)

Understanding heart failure with preserved ejection fraction: where are we today?
por: van Heerebeek, L., et al.
Publicado: (2016)

Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction
por: Yoshihisa, Akiomi, et al.
Publicado: (2020)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Left ventricular volume regulation in heart failure with preserved ejection fraction
por: Kerkhof, Peter L M, et al.
Publicado: (2013)

Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction
por: Henning, Robert J
Publicado: (2020)

Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling
por: Stencel, Jason, et al.
Publicado: (2023)

Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy
por: Stachowiak, Paweł, et al.
Publicado: (2013)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Is there a latent left ventricular dysfunction in hypertensive patients with preserved ejection fraction ?
por: Taamallah, Karima, et al.
Publicado: (2021)

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes
por: Filippatos, Gerasimos, et al.
Publicado: (2022)

Diagnostic utility of biomarkers of left ventricular stress in patients with aortic stenosis and preserved left ventricular ejection fraction
por: Sobczak, Sebastian, et al.
Publicado: (2017)

Left ventricular twist was decreased in isolated left bundle branch block with preserved ejection fraction
por: Yılmaz, Sabiye, et al.
Publicado: (2017)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

Sex differences in circulating proteins in heart failure with preserved ejection fraction
por: Stienen, Susan, et al.
Publicado: (2020)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Cardiac steatosis and left ventricular remodeling in heart failure with reduced and preserved ejection fraction
por: Mahmod, Masliza, et al.
Publicado: (2015)

The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction
por: Yamamoto, Eiichiro, et al.
Publicado: (2015)

Left Ventricular Wall Stress Is Sensitive Marker of Hypertrophic Cardiomyopathy With Preserved Ejection Fraction
por: Zhao, Xiaodan, et al.
Publicado: (2018)

Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction
por: Fujisue, Koichiro, et al.
Publicado: (2019)

Characteristics and Prognosis of Patients With Moderate Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
por: Delesalle, Geraud, et al.
Publicado: (2019)

Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction
por: Gori, Mauro, et al.
Publicado: (2020)

Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
por: Garg, Pankaj, et al.
Publicado: (2021)

Left ventricular geometry transition in hypertensive patients with heart failure with preserved ejection fraction
por: Guan, Ping, et al.
Publicado: (2021)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients
por: Mark, Patrick B, et al.
Publicado: (2022)

Left ventricular strain patterns and their relationships with cardiac biomarkers in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction
por: Zhang, Lisha, et al.
Publicado: (2022)

Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
por: van Heerebeek, Loek, et al.
Publicado: (2013)

Circulating troponin and further left ventricular ejection fraction improvement in patients with previously recovered left ventricular ejection fraction
por: Howlett, Jonathan G., et al.
Publicado: (2020)

Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction
por: Zhu, Ning, et al.
Publicado: (2019)

Risk and predictors of dyssynchrony cardiomyopathy in left bundle branch block with preserved left ventricular ejection fraction
por: Sharma, Sunita, et al.
Publicado: (2020)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
por: Dabiri, Yaghoub, et al.
Publicado: (2018)

Global Left Ventricular Myocardial Work Efficiency in Patients With Severe Rheumatic Mitral Stenosis and Preserved Left Ventricular Ejection Fraction
por: Rudiktyo, Estu, et al.
Publicado: (2023)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
por: McManus, David D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_otj4gdu418i1rbn5h5begp51bd